Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Pfizer 14.451, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
Pfizer vs CSL Net Worth and Market Cap
Pfizer (PFE) and CSL (CSL.AX) are peers in Vaccines. Pfizer reported revenue of $14.5B as of Q1 2026, compared with $7.3B for CSL. Pfizer leads on revenue.
Pfizer's gross margin is 67.3% versus 44.4% for CSL. Pfizer's net margin is 18.6% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, CSL.| Metric | Pfizer | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $14.45B | $7.30B |
| Cost of Revenue | $4.73B | $4.06B |
| Gross Profit | $9.72B | $3.24B |
| Operating Income | $4.03B | $1.39B |
| Net Income | $2.69B | $-2.94B |
| R&D Expense | $2.63B | $614.00M |
| Earnings Per Share | $0.47 | -$6.14 |
| Gross Margin | 67.3% | 44.4% |
| Operating Margin | 27.9% | 19.0% |
| Net Profit Margin | 18.6% | -40.2% |
| Free Cash Flow | $2.18B | $1.76B |
| Cumulative Free Cash Flow | $356.40B | $21.56B |
| Operating Cash Flow | $2.62B | $2.09B |
| Cash & Equivalents | $1.70B | $1.51B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.